BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report)’s stock price rose 0.2% on Monday . The company traded as high as $0.16 and last traded at $0.16. Approximately 1,350 shares changed hands during mid-day trading, an increase of 3% from the average daily volume of 1,310 shares. The stock had previously closed at $0.16.
BioNxt Solutions Trading Up 0.2 %
The firm has a market cap of $17.94 million, a price-to-earnings ratio of -3.17 and a beta of 0.82. The firm has a 50-day moving average of $0.18 and a two-hundred day moving average of $0.25.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last posted its quarterly earnings data on Wednesday, August 28th. The company reported ($0.01) earnings per share for the quarter.
BioNxt Solutions Company Profile
BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.
Read More
- Five stocks we like better than BioNxt Solutions
- Technology Stocks Explained: Here’s What to Know About Tech
- The Average 401k Balance by Age Explained
- 5 discounted opportunities for dividend growth investors
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- 3 REITs to Buy and Hold for the Long Term
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
